Evidence map›Paper›PMID 42626179›Full record

ArticleACS omega2026

Machine Learning Prediction and Experimental Validation of Antimicrobial Peptide Activity Differences against Gram-Positive and Gram-Negative Bacteria.

Peicheng Lu, Wenhao Li, Muhammad Zubair, Leyu Li, Guomin Han, Ying Chu

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Peicheng LuSchool of Life Sciences, Anhui Agricultural University, Hefei 230036, China.
Wenhao LiSchool of Life Sciences, Anhui Agricultural University, Hefei 230036, China.
Muhammad ZubairCentral Laboratory, Jiangsu University Affiliated Wujin Hospital, Changzhou 213017, China.
Leyu LiSchool of Life Sciences, Anhui Agricultural University, Hefei 230036, China.
Guomin HanSchool of Life Sciences, Anhui Agricultural University, Hefei 230036, China.ORCID https://orcid.org/0000-0002-1199-4448
Ying ChuCentral Laboratory, Jiangsu University Affiliated Wujin Hospital, Changzhou 213017, China.ORCID https://orcid.org/0009-0005-3312-176X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are primary candidates for addressing bacterial resistance. Although their target spectrum specificity varies significantly between Gram-positive and Gram-negative bacteria, current predictive models generally lack experimental validation. In this study, we constructed various machine learning models based on known sequences to systematically evaluate the performance of k-mer frequencies, physicochemical properties, and hybrid features in distinguishing the AMP target specificity. Results indicated that the random forest model based on eight key physicochemical properties performed best, achieving a test set accuracy of 82.09% with balanced classification and robust generalization. Feature importance analysis revealed that hydrophilicity and isoelectric point (pI) are the core physicochemical factors determining the target spectrum differences. The model was rigorously validated through a dual-track approach: first, via the synthesis and in vitro testing of 18 novel protozoan-derived AMPs (overall accuracy 66.67%) and, second, through a blind test on 55 independent external sequences, achieving a robust accuracy of 81.82%. Furthermore, the framework successfully identified candidates with potent activity against multidrug-resistant pathogens including

Identifiers

PMID42626179
PMCPMC13491888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.